These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 39175523)
1. HIV-1 and methamphetamine co-treatment in primary human astrocytes: TAARgeting ER/UPR dysfunction. Proulx JM; Park IW; Borgmann K NeuroImmune Pharm Ther; 2024 Jun; 3(2):139-154. PubMed ID: 39175523 [TBL] [Abstract][Full Text] [Related]
2. A Non-Canonical Role for IRE1α Links ER and Mitochondria as Key Regulators of Astrocyte Dysfunction: Implications in Methamphetamine use and HIV-Associated Neurocognitive Disorders. Proulx J; Stacy S; Park IW; Borgmann K Front Neurosci; 2022; 16():906651. PubMed ID: 35784841 [TBL] [Abstract][Full Text] [Related]
3. Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Cisneros IE; Ghorpade A Neuropharmacology; 2014 Oct; 85():499-507. PubMed ID: 24950453 [TBL] [Abstract][Full Text] [Related]
4. Methamphetamine Activates Trace Amine Associated Receptor 1 to Regulate Astrocyte Excitatory Amino Acid Transporter-2 via Differential CREB Phosphorylation During HIV-Associated Neurocognitive Disorders. Cisneros IE; Ghorpade A; Borgmann K Front Neurol; 2020; 11():593146. PubMed ID: 33324330 [TBL] [Abstract][Full Text] [Related]
5. HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses. Nooka S; Ghorpade A Cell Death Discov; 2017; 3():17061. PubMed ID: 29354290 [TBL] [Abstract][Full Text] [Related]
6. Methamphetamine Augments Concurrent Astrocyte Mitochondrial Stress, Oxidative Burden, and Antioxidant Capacity: Tipping the Balance in HIV-Associated Neurodegeneration. Borgmann K; Ghorpade A Neurotox Res; 2018 Feb; 33(2):433-447. PubMed ID: 28993979 [TBL] [Abstract][Full Text] [Related]
7. Cal'MAM'ity at the Endoplasmic Reticulum-Mitochondrial Interface: A Potential Therapeutic Target for Neurodegeneration and Human Immunodeficiency Virus-Associated Neurocognitive Disorders. Proulx J; Park IW; Borgmann K Front Neurosci; 2021; 15():715945. PubMed ID: 34744606 [TBL] [Abstract][Full Text] [Related]
8. HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity. Yu C; Narasipura SD; Richards MH; Hu XT; Yamamoto B; Al-Harthi L Aging Cell; 2017 Oct; 16(5):956-965. PubMed ID: 28612507 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation. Fan Y; He JJ J Biol Chem; 2016 Oct; 291(43):22819-22829. PubMed ID: 27609520 [TBL] [Abstract][Full Text] [Related]
10. Methamphetamine decreases K Dave S; Chen L; Yu C; Seaton M; Khodr CE; Al-Harthi L; Hu XT J Neurochem; 2019 Jan; 148(1):29-45. PubMed ID: 30295919 [TBL] [Abstract][Full Text] [Related]
11. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. Langford D; Grigorian A; Hurford R; Adame A; Crews L; Masliah E J Neurovirol; 2004 Dec; 10(6):327-37. PubMed ID: 15765804 [TBL] [Abstract][Full Text] [Related]
12. Methamphetamine compromises gap junctional communication in astrocytes and neurons. Castellano P; Nwagbo C; Martinez LR; Eugenin EA J Neurochem; 2016 May; 137(4):561-75. PubMed ID: 26953131 [TBL] [Abstract][Full Text] [Related]
13. HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Borgmann K; Ghorpade A Front Microbiol; 2015; 6():1143. PubMed ID: 26579077 [TBL] [Abstract][Full Text] [Related]
14. Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Simmen T; Lynes EM; Gesson K; Thomas G Biochim Biophys Acta; 2010 Aug; 1798(8):1465-73. PubMed ID: 20430008 [TBL] [Abstract][Full Text] [Related]
15. Methamphetamine and HIV-1 Tat down regulate β-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity. Sharma A; Hu XT; Napier TC; Al-Harthi L J Neuroimmune Pharmacol; 2011 Dec; 6(4):597-607. PubMed ID: 21744004 [TBL] [Abstract][Full Text] [Related]
16. Transfer of neuron-derived α-synuclein to astrocytes induces neuroinflammation and blood-brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1. Huang J; Ding J; Wang X; Gu C; He Y; Li Y; Fan H; Xie Q; Qi X; Wang Z; Qiu P Brain Behav Immun; 2022 Nov; 106():247-261. PubMed ID: 36089218 [TBL] [Abstract][Full Text] [Related]
17. Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction. Ng NS; Newbery M; Touffu A; Maksour S; Chung J; Carroll L; Zaw T; Wu Y; Ooi L CNS Neurosci Ther; 2023 Sep; 29(9):2481-2497. PubMed ID: 36971196 [TBL] [Abstract][Full Text] [Related]
18. Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure. Tjitro R; Campbell LA; Basova L; Johnson J; Najera JA; Lindsey A; Marcondes MCG Front Immunol; 2018; 9():3110. PubMed ID: 30778358 [TBL] [Abstract][Full Text] [Related]
19. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment. Pei Y; Asif-Malik A; Hoener M; Canales JJ Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165 [TBL] [Abstract][Full Text] [Related]